Raleukin
Raleukin (Anakinra/AMG-719), a recombinant, nonlysozymatized IL-1R antagonist, is the first-line agent for the treatment of hemophagocytic lymphohistiocytosis (HLH) and the first biologic agent to block pro-inflammatory effects.
Alternate Names |
Anakinra, AMG-719 |
Source |
Escherichia coli. |
M.Wt |
17257.6 |
Cas No. |
143090-92-0 |
Appearance |
Liquid |
Formula |
C759H1186N208O232S10 |
Cell experiment |
Proliferation, migration, and invasion: After an IL-1β (10 ng/mL)stimulation period of 3h, administration of anakinra (1 µg/mL, 48 h) strongly diminished expression of these cytokines in GBM and PBMC. Anakinra Dampened IL-1β-Induced Inflammatory Gene Expression in both cell populations1. ChIP assay: MEF cells were grown on 100 mm plates incubated with 10 μg/mL anakinra for 4 hours. Cells were then recovered in PBS 1× with MgCl2 1 mM, exposed to 1% formaldehyde at room temperature for 15 minutes to induce DNA crosslinking, washed, and then lysed with RIPA buffer containing 150 mM NaCl, 50 mM Tris pH 8.0, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% PIC, and PMSF2. |
Animal experiment |
C57BL6 WT mice were treated (i.p.) with 10 mg/kg anakinra reconstituted in sterile water daily for 6 consecutive days beginning the day of the infection2. |
Target |
IL-1 |
Pathway |
Immunology/Inflammation |
Stability & Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles |
Shipping Condition |
Dry ice |
Handling |
Centrifuge the vial prior to opening. |
Usage |
For Research Use Only! Not to be used in humans. |
M.Wt | 17257.6 |
Cas No. | 143090-92-0 |
Formula | C759H1186N208O232S10 |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & DataSheet
- View current batch:
-
Purity ≥ 95 % by SDS-PAGE and HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet